Navigation Links
Bayer CropScience Releases Video About Making Science Make Sense Program At Durham Performance Learning Center
Date:6/14/2011

RESEARCH TRIANGLE PARK, N.C., June 14, 2011 /PRNewswire/ -- Bayer CropScience (http://www.bayercropscience.us), one of the world's top innovative crop science companies in the areas of crop protection, non-agricultural pest control, seeds and traits, has announced the release of a video featuring the organization's work at Durham Performance Learning Center through its national award-winning program, Making Science Make Sense (MSMS). MSMS advances science literacy through hands-on, inquiry-based science learning, employee volunteerism and public education. Through its work with the Durham Performance Learning Center, Bayer aims to showcase the exciting parts of science to increase interest among students and give them more of a hands-on background in science. The video is available for viewing at: http://www.bayercropscience.us/our-commitment/making-science-make-sense.

Bayer's MSMS team has led biology labs at Durham Performance Learning Center for the past two years. As a result of the team's efforts, more than 50 percent of the students participating in the MSMS biology lab passed the End of Course exam. The center's science teacher credits the students' success to participation in the MSMS labs.

QUOTES:

"At Bayer CropScience, one of our sayings is 'science for a better life,'" said Adrian Percy, vice president, development and market support at Bayer CropScience. "Several students at the Durham Performance Learning Center would not have graduated without passing biology. Helping these students graduate not only helps them with their future career, it also has a substantial impact on our state's economic health."    

DETAILS:

- MSMS is one of Bayer's 300 worldwide corporate responsibility programs.

- Each semester, Bayer CropScience's MSMS team leads biology students through approximately six two-hour labs. The labs are interactive and designed to cover key biological concepts.

- Between 10 and 20 students participate in each lab. In the 2011 spring semester, students took three field trips to the Bayer CropScience campus: Crop Protection Headquarters (RTP); Biotechnology Innovation Center (Morrisville); and Environmental Science Field Technology (Clayton).  

- To learn more about the Making Science Make Sense program, visit http://www.bayerus.com/MSMS/MSMS_Home.aspx.

- For more information about the Durham Performance Learning Center, visit http://dplc.dpsnc.net/index.php.

ABOUT BAYER CROPSCIENCE:

Bayer is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Bayer CropScience, a subgroup of Bayer AG with annual sales of EUR 6.830 billion (2010), is one of the world's leading innovative crop science companies in the areas of crop protection, non-agricultural pest control, seeds and traits. The company offers an outstanding range of products and extensive service backup for modern, sustainable agriculture and for non-agricultural applications. Bayer CropScience has a global workforce of 20,700 and is represented in more than 120 countries. This and further news is available at: http://www.press.bayercropscience.com.

ABOUT BAYER USA FOUNDATION:

Partnering with community leaders and providing philanthropic support have long been a part of Bayer Corporation's culture. In 1953, Bayer created the first of three foundations that later all merged to become the Bayer USA Foundation. The Bayer USA Foundation is an endowed 501(c)(3) entity and is the primary source for Bayer's philanthropic giving throughout the United States. The mission of the Bayer USA Foundation is to support programs that enhance the quality of life, provide unique and enriching opportunities that connect diverse groups and ensure preparedness for tomorrow's leaders — thereby, resulting in sustainable partnerships that continually improve communities in which Bayer employees live and work. 

This news release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at http://www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

Media Contacts:

Jennifer Fair
MMI Public Relations
(919) 233-6600
jennifer@mmipublicrelations.com    
http://www.twitter.com/MMIPR  
http://www.mmipublicrelations.com/

Patty Briguglio
MMI Public Relations
(919) 233-6600
patty@mmipublicrelations.com

Beth Roden
Bayer CropScience
(919) 549-2030
Beth.roden@bayer.com
USA-BCS-2011-0398  


'/>"/>
SOURCE Bayer CropScience
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. FDA Grants Fast Track Designation to Bayers Investigational Compound Regorafenib for the Treatment of Gastrointestinal Stromal Tumors
2. OncoMed Pharmaceuticals and Bayer Schering Pharma Announce Strategic Alliance to Develop Anti-Cancer Stem Cell Therapeutics
3. Arthur J. Higgins, CEO of Bayer HealthCare, Appointed to Resverlogix Board of Directors
4. Blue Dye Test Alternative Installed at Bayer China for Packaging Quality Assurance Process
5. Inspiring New Online Destination From Bayer Diabetes Care
6. Bayer Acquires Two Prescription Dermatology Product Lines From SkinMedica in the U.S.
7. Bayer CropScience Announces Investment of $25 Million for Institute Site
8. Bayers CONTOUR and Bayers BREEZE2 Blood Glucose Monitoring Systems Do Not Use Problematic GDH-PQQ Technology
9. DuPont and Bayer CropScience Expand Collaboration With Broad License Agreements
10. Neptune Products to be commercialized by BAYER HealthCare
11. Onyx Pharmaceuticals Files Complaint Against Bayer Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... , ... June 27, 2016 , ... Parallel 6 ... trials, announced today the Clinical Reach Virtual Patient Encounter CONSULT module which ... with the physician and clinical trial team. , Using the CONSULT module, patients and ...
(Date:6/27/2016)... 27, 2016  Liquid Biotech USA ... of a Sponsored Research Agreement with The University ... (CTCs) from cancer patients.  The funding will be ... correlate with clinical outcomes in cancer patients undergoing ... then be employed to support the design of ...
(Date:6/24/2016)... DIEGO , June 24, 2016 ... more sensitively detects cancers susceptible to PARP inhibitors ... circulating tumor cells (CTCs). The new test has ... HRD-targeted therapeutics in multiple cancer types. ... targeting DNA damage response pathways, including PARP, ATM, ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, a ... eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced clinical research ... by providing practical tips, tools, and strategies for clinical researchers. , “The landscape ...
Breaking Biology Technology:
(Date:5/9/2016)... 2016 Elevay is currently known ... freedom for high net worth professionals seeking travel for ... connected world, there is still no substitute for a ... sealing your deal with a firm handshake. This is ... advantage of citizenship via investment programs like those offered ...
(Date:4/28/2016)... Sweden , April 28, 2016 First ... M (139.9), up 966% compared with the first quarter of 2015 ... profit totaled SEK 589.1 M (loss: 18.8) and the operating margin ... 7.12 (loss: 0.32) Cash flow from operations was SEK ... The 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. ...
(Date:4/19/2016)... 2016 The new GEZE SecuLogic ... web-based "all-in-one" system solution for all door components. It ... the door interface with integration authorization management system, and ... The minimal dimensions of the access control and the ... installations offer considerable freedom of design with regard to ...
Breaking Biology News(10 mins):